Don't the Swiss also have very fancy stuff, though?
But yeah, drug pricing might be a significant part. I'm not sure about the reduced incentives for pharmaceutical companies, though? From what I understand the system is very inefficient, there are a lot of middlemen (i.e. waste) involved and price discrimination going on so a lot of that money might not necessarily be going to the drug companies doing the research.
But yeah, drug pricing might be a significant part. I'm not sure about the reduced incentives for pharmaceutical companies, though? From what I understand the system is very inefficient, there are a lot of middlemen (i.e. waste) involved and price discrimination going on so a lot of that money might not necessarily be going to the drug companies doing the research.